Silverarc Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.6M	Buy	306,000 +170,050	+125%	+$16.5M	3.14%	14
2025 Q4	$14.6M	Sell	135,950 -234,046	-63%	-$24.8M	2.11%	16
2025 Q3	$37.4M	Sell	369,996 -30,776	-8%	-$2.86M	5.41%	2
2025 Q2	$25.3M	Buy	400,772 +63,167	+19%	+$3.87M	5.18%	5
2025 Q1	$17.9M	Buy	337,605 +63,709	+23%	+$3.53M	3.74%	8
2024 Q4	$15.3M	Buy	273,896 +18,318	+7%	+$1.01M	3.43%	11
2024 Q3	$13.4M	Buy	255,578 +70,916	+38%	+$3.4M	3.02%	8
2024 Q2	$7.58M	Buy	184,662 +886	+0.5%	+$35.4K	1.87%	19
2024 Q1	$7.96M	Buy	183,776 +9,528	+5%	+$417K	2.23%	14
2023 Q4	$8.01M	Sell	174,248 -86,289	-33%	-$2.72M	2.47%	14
2023 Q3	$5.97M	Buy	260,537 +144,369	+124%	+$3.23M	2.23%	21
2023 Q2	$1.92M	Buy	+116,168	New	+$2.1M	0.65%	47